Donald Trump announced phased tariffs on imported generic medicines starting August 2026. These tariffs will gradually increase to 200 percent over three years. This policy aims to reshore pharmaceutical production back into America. India, a major supplier of affordable generics, faces significant impact from these changes. The move adds uncertainty to ongoing bilateral trade agreement.
Related Posts
‘I challenge them to join BJP’: Mamata shuts down door on TMC rebels
Trinamool Congress chief Mamata Banerjee declared defectors will not be readmitted to the party. She asserted that many capable individuals…
Turkey’s S-400 gamble: How a Gulf sale could redraw West Asia’s air defence map
In a significant development, Turkey is exploring the sale of its Russian S-400 air defence systems to the UAE. This…
Twist in Balogun row: Belgium allowed to appeal against FIFA decision; what it means
Balogun had been due to miss the United States’ FIFA World Cup round-of-16 match against Belgium after receiving a direct…